{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EBV&page=2", "query": { "intervention": "EBV", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EBV&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-13T03:44:03.846Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01475058", "title": "CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia", "Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Mantle Cell Lymphoma", "Refractory Chronic Lymphocytic Leukemia" ], "interventions": [ { "name": "allogeneic cytomegalovirus-specific cytotoxic T lymphocytes", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1, "start_date": "2012-04", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2017-02-15", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01475058" }, { "nct_id": "NCT02285062", "title": "Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lymphoma, Large B-Cell, Diffuse" ], "interventions": [ { "name": "lenalidomide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "vincristine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 570, "start_date": "2015-02-17", "completion_date": "2022-07-28", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 22, "location_summary": "Fayetteville, Arkansas • Orange, California • Sacramento, California + 16 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02285062" }, { "nct_id": "NCT05236764", "title": "Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission", "Myelodysplastic Syndromes", "Chronic Myeloid Leukemia", "Hemophagocytic Lymphohistiocytoses", "Primary Immunodeficiency Diseases", "Hemoglobinopathies", "Severe Aplastic Anemia", "Cytopenia", "Bone Marrow Failure Syndrome", "Severe Chronic Active Epstein-Barr Virus Infection" ], "interventions": [ { "name": "CliniMACS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "55 Years", "sex": "ALL", "summary": "Up to 55 Years" }, "enrollment_count": 3, "start_date": "2023-12-06", "completion_date": "2026-05-23", "has_results": true, "last_update_posted_date": "2025-10-30", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05236764" }, { "nct_id": "NCT02048332", "title": "Donor-Derived Viral Specific T-cells (VSTs)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Allogeneic Stem Cell Transplant", "Viral Infection", "Viral Reactivation" ], "interventions": [ { "name": "Viral specific VST Infusion", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Weeks", "maximum_age": null, "sex": "ALL", "summary": "4 Weeks and older" }, "enrollment_count": 1000, "start_date": "2014-02-05", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 3, "location_summary": "Akron, Ohio • Cincinnati, Ohio", "locations": [ { "city": "Akron", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02048332" }, { "nct_id": "NCT05433961", "title": "Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COPD" ], "interventions": [ { "name": "MagniXene Hyperpolarized Xenon MRI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Xemed LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 27, "start_date": "2023-10-20", "completion_date": "2025-09-11", "has_results": false, "last_update_posted_date": "2025-09-30", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05433961" }, { "nct_id": "NCT06909110", "title": "Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Adenovirus", "Cytomegalovirus Infections", "Epstein-Barr Virus Infections" ], "interventions": [ { "name": "Adenovirus Specific T- Lymphocytes", "type": "BIOLOGICAL" }, { "name": "Cytomegalovirus Specific T-Lymphocytes", "type": "BIOLOGICAL" }, { "name": "Epstein-Barr Virus Specific T-Lymphocytes", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Jessie L. Alexander", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "65 Years", "sex": "ALL", "summary": "1 Month to 65 Years" }, "enrollment_count": 25, "start_date": "2025-04-30", "completion_date": "2032-01-01", "has_results": false, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 3, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06909110" }, { "nct_id": "NCT00521001", "title": "Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Melanoma (Skin)" ], "interventions": [ { "name": "everolimus", "type": "DRUG" }, { "name": "temozolomide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2008-01", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2017-08-14", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 198, "location_summary": "Aurora, Colorado • Boulder, Colorado • Colorado Springs, Colorado + 124 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00521001" }, { "nct_id": "NCT03475212", "title": "Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cytomegalovirus Infections", "Adenovirus Infection", "EBV Infection" ], "interventions": [ { "name": "Virus Specific T-cell (VST) infusion", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pediatric Transplantation & Cellular Therapy Consortium", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 52, "start_date": "2018-06-20", "completion_date": "2025-06-30", "has_results": false, "last_update_posted_date": "2025-05-11", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Duarte, California • Los Angeles, California + 24 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03475212" }, { "nct_id": "NCT06908096", "title": "Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "EBV", "Epstein-Barr Virus Infection", "Infectious Mononucleosis", "Mono" ], "interventions": [ { "name": "EBV gp350-ferritin vaccine with ALFQ adjuvant", "type": "BIOLOGICAL" }, { "name": "EBV gH/gL/gp42-ferritin nanoparticle vaccine with ALFQ adjuvant", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "18 Years to 29 Years" }, "enrollment_count": 750, "start_date": "2025-05-29", "completion_date": "2028-10-01", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06908096" }, { "nct_id": "NCT01386359", "title": "Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Kidney Transplantation" ], "interventions": [ { "name": "No Intervention", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 914, "start_date": "2012-02-29", "completion_date": "2019-04-30", "has_results": false, "last_update_posted_date": "2022-06-06", "last_synced_at": "2026-09-13T03:44:03.846Z", "location_count": 36, "location_summary": "Tucson, Arizona • Los Angeles, California • San Diego, California + 26 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01386359" } ] }